Latest filing published 04 Oct 2018 for Vicore Pharma Holding AB, €32k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Leif Darner: trading record in brief
Leif Darner is a declared insider of Vicore Pharma Holding AB, with filings sourced from Finansinspektionen. In total, 4 filings cover trades dated from 25 August 2016 to 3 October 2018.
No open-market sale appears; the market trades are 4 purchases worth €228k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2018: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €26k. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 4 October 2018: an open-market purchase of €32k, in Vicore Pharma Holding AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Leif Darner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 33,333 shares@ SEK 10.0016.3% of flowBTA (betald tecknad aktie)ISIN SE0011670223FI:csv-97e190ab04b342f9c143Canonical exit: 1 Jan 2019 (T+90)
- 100,000 shares@ SEK 16.0083.7% of flowFI:csv-16e7490fb4531e393b6cCanonical exit: 15 Aug 2017 (T+90)
- 10,000 shares@ SEK 19.499563.5% of flowISIN SE0007577895FI:csv-12b00b494b342476dcd6Canonical exit: 25 May 2017 (T+90)
- 10,000 shares@ SEK 11.185236.5% of flowFI:csv-98e6693a81f9bd04292eCanonical exit: 23 Nov 2016 (T+90)
4 of 4 declarations